Erratum: Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death (Neurochemical Research DOI: 10.1007/s11064-010-0336-7);Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death

Neurochemical Research

Volumn 36, Issue 9, 2011, Pages 1587-1593

  Smith, Joshua A ^a   Das, Arabinda ^a   Butler, Jonathan T ^a   Ray, Swapan K ^b   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; Estrogen receptor beta; Lipopolysaccharide estrogen receptor alpha; Microglia

Indexed keywords

CALPAIN; CALPASTATIN; CYCLOOXYGENASE 2; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA AGONIST; ESTROGEN RECEPTOR BETA AGONIST; FULVESTRANT; HORMONE RECEPTOR STIMULATING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG EXPOSURE; ENZYME RELEASE; INHIBITION KINETICS; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

RATTUS;

EID: 80755189035     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0429-y     Document Type: Erratum

References (37)

1. Calabrese V, Scapagnini G, Ravagna A et al (2002) Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 70:580-587 (Pubitemid 35253528)
2. McGeer PL, McGeer EG (2007) NSAIDs and Alzheimer disease: Epidemiological, animal model, and clinical studies. Neurobiol Aging 28:639-647 (Pubitemid 46349357)
3. Zandi PP, Anthony JC, Hayden KM et al (2002) Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study. Neurology 59:880-886
4. Hanisch UK, Kettenmann H (2007) Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387-1394 (Pubitemid 350014685)
5. Kreutzberg GW (1996) Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318 (Pubitemid 26349059)
6. Dheen ST, Kaur C, Ling EA (2007) Microglia activation and its implications in the brain diseases. Curr Med Chem 14:1189-1197 (Pubitemid 46739320)
7. McGeer PL, Kawamata T, Walker DG (1993) Microglia in degenerative neurological disease. Glia 7:84-92
8. Aktas O, Smorodchenko A, Brocke S (2005) Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 46:421-432 (Pubitemid 40616886)
9. Purisai MG, McCormack AL, Cumine S (2007) Microglia activation as a priming event lead to paraquat-induced dopaminergic cell degeneration. Neurobiol Dis 25:392-400 (Pubitemid 46124019)
10. Dickson DW, Lee SC, Mattiace SH et al (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83
11. Henkel JS, Engelhardt JI, Siklos L (2004) Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55:221-235 (Pubitemid 38166999)
12. Garay L, Gonzalez Deniselle MC, Gierman L et al (2008) Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 15:76-83
13. Jia J, Guan D, Zhu W et al (2009) Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Exp Neurol 215:48-52
14. Morissette M, Al Sweidi S, Callier S et al (2008) Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol Cell Endocrinol 290:60-69
15. Bayir H, Marion DW, Puccio AM et al (2004) Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J Neurotrauma 21:1-8 (Pubitemid 38141797)
16. Bode FJ, Stephan M, Suhling H et al (2008) Sex differences in a transgenic rat model of Huntington's disease: Decreased 17 beta-estradiol levels correlate with reduced numbers of DARPP32 ? neurons in males. Hum Mol Gen 17:2595-2609
17. Frutiger K, Lukas TJ, Gorrie G et al (2008) Gender differences in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9:184-187 (Pubitemid 351983181)
18. Kupina NC, Detloff MR, Bobrowski WF et al (2003) Cytoskeletal protein degradation and neurodgeneration evolves differently in males and females following experimental head injury. Exp Neurol 180:55-73
19. Dimayuga FO, Reed JL, Carnero GA et al (2005) Estrogen and brain inflammation: Effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol 161: 123-136 (Pubitemid 40340880)
20. Moosmann B, Behl C (1999) The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 96: 8867-8872 (Pubitemid 29374674)
21. Tripanichkul W, Sripanichkulchai K, Finkelstein DI (2006) Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine intoxication. Brain Res 1084:28-37
22. Vegeto E, Bonincontro C, Pollio G (2001) Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 21:1809-1818 (Pubitemid 32221364)
23. Bruce-Keller AJ, Keeling JL, Keller JN (2000) Antiinflammatory effects of estrogen on microglial activation. Endocrinology 141:3646-3656
24. Drew PD, Chavis JA (2000) Female sex steroids: Effects upon microglial cell activation. J Neuroimmunol 111:77-85
25. Zemlyak I, Brooke S, Sapolsky R (2005) Estrogenic protection against gp120 neurotoxicity: Role of microglia. Brain Res 1046: 130-136 (Pubitemid 40775882)
26. Baker AE, Brautigam VM, Watters JJ (2004) Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 145:5021-5032 (Pubitemid 39551121)
27. Liu X, Fan XL, Zhao Y et al (2005) Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia. J Neurosci Research 81:653-665 (Pubitemid 41532161)
28. Tapia-Gonzalez S, Carrero P, Pernia O et al (2008) Selective estrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: Potential role of microglial ERs. J Endocrinol 198:219-230 (Pubitemid 352038201)
29. Das A, Sribnick EA, Wingrave JM et al (2005) Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: Calpain inhibition provides functional neuroprotection. J Neurosci Res 81:551-562 (Pubitemid 41297392)
30. Das A, Banik NL, Ray SK (2009) Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells. Neurochem Res 34:87-101
31. Davidge ST, Baker PN, Laughlin MK et al (1995) Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77: 274-283
32. Ray SK, Neuberger TJ, Deadwyler G et al (2002) Calpain and calpastatin expression in primary oligodendrocyte culture: Preferential localization of membrane calpain in cell processes. J Neurosci Res 70:561-569 (Pubitemid 35253526)
33. Pan XD, Chen XC, Zhu YG et al (2008) Neuroprotective role of tripchloride on inflammatory neurotoxicity induced by lipopolysaccharide- activated microglia. Biochem Pharmacol 76:362-372
34. Sribnick EA, Ray SK, Banik NL (2004) Estrogen as a multiactive neuroprotective agent in traumatic injuries. Neurochem Res 29:2007-2014 (Pubitemid 39663879)
35. Sawada H, Shimohama S (2000) Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev 24:143-147 (Pubitemid 30026157)
36. Tiwari-Woodruff S, Morales LB, Lee R et al (2007) Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER) alpha and ERbeta ligand treatment. Proc Natl Acad Sci USA 104:14813-14818 (Pubitemid 350003225)
37. Crawford DK, Mangiardi M, Song B et al (2010) Oestrogen receptor beta ligand: A novel treatment to enhance endogenous functional remyelination. Brain 133:2999-3016